Literature DB >> 15822051

Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes.

Grzegorz Placha1, Luis H Canani, James H Warram, Andrzej S Krolewski.   

Abstract

Proteinuria and impaired kidney function are 2 major traits of diabetic nephropathy that aggregate (are heritable) in families of diabetic individuals. Although both traits are heritable, they are not genetically correlated. These findings not only support the hypothesis that the development of diabetic nephropathy consists of 2 distinct disease processes (ie, increasing proteinuria and declining kidney function) but also strongly justify searches for the putative genes that separately determine variation in these processes. These searches have used both genome-wide scans and candidate-gene approaches. By use of genome-scan approaches, several research groups have identified genetic regions on chromosomes 7q, 18q, and 22q that harbor genes that determine either variation in urinary albumin excretion or susceptibility to proteinuria in families who have type 2 diabetes. The evidence for linkage in these 3 genetic regions was suggestive or strong, but, except for 7q, the regions did not overlap across studies. Two genome scans performed in families who have type 2 diabetes identified genetic regions on chromosome 3q, 6q, 7p, and 18q that harbor susceptibility genes that determine variation in glomerular filtration rate or susceptibility to the development of end-stage renal disease (ESRD). The region on 7p overlapped in both studies. Optimism is growing that a positional cloning approach applied to these putative genetic regions will lead to the isolation of the susceptibility genes for proteinuria and ESRD. Meanwhile, significant efforts that make use of the candidate-gene approach have been directed to the search for susceptibility genes for diabetic nephropathy. Unfortunately, positive findings have not been consistent.

Entities:  

Mesh:

Year:  2005        PMID: 15822051     DOI: 10.1053/j.ackd.2005.02.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  31 in total

1.  Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.

Authors:  Jean W MacCluer; Marina Scavini; Vallabh O Shah; Shelley A Cole; Sandra L Laston; V Saroja Voruganti; Susan S Paine; Alfred J Eaton; Anthony G Comuzzie; Francesca Tentori; Dorothy R Pathak; Arlene Bobelu; Jeanette Bobelu; Donica Ghahate; Mildred Waikaniwa; Philip G Zager
Journal:  Am J Kidney Dis       Date:  2010-06-19       Impact factor: 8.860

2.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Authors:  Salvatore De Cosmo; Antonio Minenna; Yuan-Yuan Zhang; Ryan Thompson; Robert Thompson; Giuseppe Miscio; Monica Vedovato; Anna Rauseo; Alois Saller; Sandra Mastroianno; Fabio Pellegrini; Roberto Trevisan; Paola Fioretto; Alessandro Doria; Vincenzo Trischitta
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

3.  The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.

Authors:  Ming Lu; Jianzhong Zhang; Ming Li; Xiaoxu Ge; Xu Dai; Jiao Zhao; Mingzhou Fu; Tao Wang; Xiyao Fang; Can Li; Rong Zhang; Weijing Zhao; Taishan Zheng; Feng Wang; Ming Yu; Tao Lei; Niansong Wang; Yuqian Bao; Limei Liu; Yanjun Liu; Weiping Jia
Journal:  Mol Cell Biochem       Date:  2016-09-16       Impact factor: 3.396

4.  A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS.

Authors:  Nedal H Arar; Venkata S Voruganti; Subrata D Nath; Farook Thameem; Richard Bauer; Shelley A Cole; John Blangero; Jean W MacCluer; Anthony G Comuzzie; Hanna E Abboud
Journal:  Nephrol Dial Transplant       Date:  2008-04-28       Impact factor: 5.992

Review 5.  Genetics of kidney failure and the evolving story of APOL1.

Authors:  David J Friedman; Martin R Pollak
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 6.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

7.  Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.

Authors:  Zongzhong Tong; Zhenglin Yang; Shrena Patel; Haoyu Chen; Daniel Gibbs; Xian Yang; Vincent S Hau; Yuuki Kaminoh; Jennifer Harmon; Erik Pearson; Jeanette Buehler; Yuhong Chen; Baifeng Yu; Nicholas H Tinkham; Norman A Zabriskie; Jiexi Zeng; Ling Luo; Jennifer K Sun; Manvi Prakash; Rola N Hamam; Stephen Tonna; Ryan Constantine; Cecinio C Ronquillo; SriniVas Sadda; Robert L Avery; John M Brand; Nyall London; Alfred L Anduze; George L King; Paul S Bernstein; Scott Watkins; Lynn B Jorde; Dean Y Li; Lloyd Paul Aiello; Martin R Pollak; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

8.  Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

Authors:  Marcus G Pezzolesi; G David Poznik; Josyf C Mychaleckyj; Andrew D Paterson; Michelle T Barati; Jon B Klein; Daniel P K Ng; Grzegorz Placha; Luis H Canani; Jacek Bochenski; Daryl Waggott; Michael L Merchant; Bozena Krolewski; Lucia Mirea; Krzysztof Wanic; Pisut Katavetin; Masahiko Kure; Pawel Wolkow; Jonathon S Dunn; Adam Smiles; William H Walker; Andrew P Boright; Shelley B Bull; Alessandro Doria; John J Rogus; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-02-27       Impact factor: 9.461

9.  Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.

Authors:  Marcus G Pezzolesi; Pisut Katavetin; Masahiko Kure; G David Poznik; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

10.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.